Father of two children with Pompe disease, daughters may be less than a year away, and sons even less. He found a university professor's research promising in the treatment of Pompe disease, although this research is only in the theoretical stage. He chose to work with professors to put this research into practice. They ran into all kinds of troubles in the process of turning research findings into real medicines. First they needed to raise a capital; after a few months of starting the experiment, the investors, dissatisfied with the progress, withdrew their investment. As a last resort, they sold their company to another company. While all parties have different goals—John wants to cure his two children, a professor wants to turn his theory into reality, a company wants to profit from a new drug—there are frequent clashes between the parties, but in They agree on a new drug for Pompe disease. Based on this, in the end they succeeded.
What impresses in the film is Professor Bob's arrogant and eccentric character, which also makes the plot twists and turns frequently. But Professor Bob is caring, and he hopes his research will one day bring good news to people with Pompe disease. It is also supported by this belief that although his plan was not approved in the end, when the drug worked, he was sincerely happy for the happy smiles of his sister and brother.
The optimism shown by Meghan, a girl with Pompe disease in the film, is also impressive. Although she suffers from Pompe disease, she has never shown any pessimism. Like a normal child, she is full of interest in life. Although this is not the focus of the film, it seems to be a hint to patients not to lose confidence in themselves and not to be pessimistic.
The film's more important reminder is to do something rather than wait for a miracle to happen. It might just be that one little idea that will change the world. The film is based on a true story - in 2006, the US FDA officially approved Lumizyme for the treatment of Pompe disease.
View more about Extraordinary Measures reviews
